Trial Profile
The effects of tolvaptan treatment in chronic kidney disease patients with heart failure or liver cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 07 Mar 2016 New trial record